Status:

COMPLETED

Tele-HF: Yale Heart Failure Telemonitoring Study

Lead Sponsor:

Yale University

Collaborating Sponsors:

National Institutes of Health (NIH)

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Congestive Heart Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary purpose of this study is to determine the effectiveness of telemonitoring compared with usual guideline-based care in preventing hospitalization for heart failure patients.

Detailed Description

Heart failure (HF) is a common, costly condition characterized by recurrent periods of clinical decompensation that often lead to repeated hospitalizations (1, 2). Despite advances in the care of pati...

Eligibility Criteria

Inclusion

  • age 18 years or older
  • hospitalized for heart failure within the past 30 days
  • access to telephone line

Exclusion

  • not expected to survive 6 months due to irreversible, life-threatening condition
  • has or scheduled for cardiac transplant or LVAD
  • scheduled for CABG or PCI within 90 days
  • severe valvular disease
  • Folstein MMSE score less than 20
  • resident of a nursing home
  • currently a prisoner
  • does not speak English or Spanish

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

1660 Patients enrolled

Trial Details

Trial ID

NCT00303212

Start Date

March 1 2006

End Date

July 1 2010

Last Update

March 30 2020

Active Locations (33)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (33 locations)

1

Cardiology Associates

Mobile, Alabama, United States, 36608

2

UC Irvine Medical Center

Orange, California, United States, 92868

3

UCLA Harbor Medical Center

Torrance, California, United States, 90502

4

Department of Cardiology at Bridgeport Hospital

Bridgeport, Connecticut, United States, 06610

Tele-HF: Yale Heart Failure Telemonitoring Study | DecenTrialz